New Zealand
-
Vertex, Pharmac ink expanded funding deal
- Fri Jan 23
New Zealand to expand its initial 2023 deal to cover funded access to Vertex’s next-gen therapy, the deal including future paediatric extensions.
Read more -
NZ bill on track for faster meds access
- 24 Oct 2025
Introduced in March, amendments will deliver significant regulatory reform and faster access for New Zealanders, the Bill now set to become law.
Read more -
UCB grows access team as ex-ANZ GM moves up at Lilly
- 03 Sep 2025
Belgium pharma beefs up inhouse capabilities as a former Pfizer GM continues his upward trajectory at Lilly in the latest industry job moves.
Read more -
Pharmac brings leading advocate into the fold
- 20 Jul 2025
Malcolm Mulholland appointed Chair of new Consumer and Patient Working Group tasked with helping Pharmac ‘reset how it works with consumers’.
Read more -
New Chief Executive for Pharmac
- 17 Jun 2025
Canadian to join Pharmac from mid-September after an extensive recruitment search within New Zealand and overseas, says Pharmac Board.
Read more -
End of an era for Pharmac’s Fitt
- 30 May 2025
NZ agency farewells CEO with no replacement as Sanofi says goodbye to a senior leader and AbbVie welcomes an Associate Medical Director.
Read more -
No more funding for Pharmac in Budget
- 23 May 2025
Having secured $604 million last year, Pharmac has spent its allocation – and blood cancer patients say only one per cent of them benefited.
Read more -
Pharmac Chief Executive resigns
- 28 Feb 2025
Breaking: Long-term Pharmac agency head Sarah Fitt steps down after seven years.
Read more






